Diagnostic tools and strategies for assessing disease progression in Alkaptonuria

Bibliography

• Ranganath LR, Cox TF. Natural history of alkaptonuria revisited: analyses based on scoring systems. J Inherit Metab Dis 2011;34:1141-51
   PubMed Web of Science ®Google Scholar
• Cox TF, Ranganath L. A quantitative assessment of alkaptonuria: Testing the reliability of two disease severity scoring systems. J Inherit Metab Dis 2011;34:1153-62
   PubMedGoogle Scholar
• O”Brien WM, La Du BN, Bunim JJ. Biochemical, pathologic and clinical aspects of alcaptonuria, ochronosis and ochronotic arthropathy: review of world literature (1584–1962). Am J Med 1963;34:813-38
   Google Scholar
• Phornphutkul C, Introne WJ, Perry MB, et al. Natural history of alkaptonuria. N Engl J Med 2002;347:2111-21
   PubMed Web of Science ®Google Scholar
• Helliwell TR, Gallagher JA, Ranganath L. Alkaptonuria - a review of surgical and autopsy pathology. Histopathol 2008;53:503-12
   PubMed Web of Science ®Google Scholar
• Suwannarat P, O”Brien K, Perry MB, et al. Use of nitisinone in patients with alkaptonuria. Metabol Clin Exper 2005;54:719-28
   PubMed Web of Science ®Google Scholar
• Garrod AE. The Croonian lectures on inborn errors of metabolism. Lecture II. Alkaptonuria. Lancet 1908;2:73-9
   Google Scholar
• La Du BN, Zannoni VG, Laster L, et al. The nature of the defect in tyrosine metabolism in alcaptonuria. J Biol Chem 1958;230:251-60
   PubMed Web of Science ®Google Scholar
• Pollak MR, Chou YH, Cerda JJ, et al. Homozygosity mapping of the gene for alkaptonuria to chromosome 3q2. Nat Genet 1993;5:201-4
   PubMedGoogle Scholar
• Fernandez-Canon JM, Granadino B, Beltrán-Valero de Bernabé D, et al. The molecular basis of Alkaptonuria. Nat Genet 1996;14:19-24
   PubMed Web of Science ®Google Scholar
• Granadino B, Beltran-Valero de Bernabe D, Fernandez-Canon JM, et al. The human homogentisate 1,2 dioxigenase (HGO) gene. Genomics 1997;43:115-22
   PubMedGoogle Scholar
• Titus GP, Mueller CR, Burgner J, et al. Crystal structure of human homogentisate dioxygenase. Nat Struct Biol 2000;7:542-6
   PubMedGoogle Scholar
• La Du BN, Zannoni VG, Laster L, et al. The nature of the defect in tyrosine metabolism in alcaptonuria. J Biol Chem 1958;230:251-60
   PubMed Web of Science ®Google Scholar
• Zannoni VG, Lomtevas N, Goldfiner S. Oxidation of homogentisic acid to ochronotic pigment in connective tissue. Biochim Biophys Acta 1969;177:94
   PubMed Web of Science ®Google Scholar
• Keller JM, Macaulay W, Nercessian OA, et al. New developments in ochronosis: review of the literature. Rheumatol Int 2005;25:81-5
   PubMed Web of Science ®Google Scholar
• Taylor AM, Boyde A, Wilson PJ, et al. The role of calcified cartilage and subchondral bone in the initiation and progression of ochronotic arthropathy in alkaptonuria. Arthritis Rheum 2011;63:3887-96
   PubMedGoogle Scholar
• Zibolen M, Srsnova K, Srsen S. Increased urolithiasis in patients with alkaptonuria in childhood. Clin Genet 2000;58:79-80
   PubMedGoogle Scholar
• Venkataseshan VS, Chandra B, Graziano J, et al. Alkaptonuria and renal failure: a case report and review of the literature. Mod Pathol 1992;5:464-71
   PubMedGoogle Scholar
• Krizek V. Urolithiasis and prostatolithiasis in alcaptonuria with ochronosis. Int Urol Nephrol 1971;3:245-50
   PubMedGoogle Scholar
• Bulow C, Rosenberg J. Intrahepatic gallstones in patient with alkaptonuria. Ugeskr Laeger 2009;171:2198-9
   PubMedGoogle Scholar
• Taylor AM, Wilson PJ, Ingrams DR, et al. Calculi and intracellular ochronosis in the submandibular tissues from a patient with alkaptonuria. J Clin Pathol 2010;63:186-8
   PubMed Web of Science ®Google Scholar
• Introne WJ, Phornphutkul C, Bernardini I, et al. Exacerbation of the ochronosis of Alkaptonuria due to renal insufficiency and improvement after renal transplantation. Mol Genet Metab 2002;77:136-42
   PubMed Web of Science ®Google Scholar
• Mullan A, Cocker D, Taylor G, et al. Fatal oxidative haemolysis and methaemoglobinaemia in a patient with alkaptonuria and acute kidney injury. Clin Kidney J 2015;8(1):109-12
   PubMedGoogle Scholar
• Heng AE, Courbebaisse M, Kemeny JL, et al. Hemolysis in a patient with alkaptonuria and chronic kidney failure. Am J Kidney Dis 2010;56:1-4
   PubMedGoogle Scholar
• Abreo K, Abreo F, Zimmerman SW, et al. A fifty-year-old man with skin pigmentation, arthritis, chronic renal failure and methemoglobinaemia. Amer J Med Genet 1983;14:97-114
   PubMedGoogle Scholar
• Essalmi L, Roncato M, Mermet I, et al. [Bluish-brown sclera and ears]. Rev Med Int 2007;28:42-3
   PubMedGoogle Scholar
• Ranganath LR, Jarvis JC, Gallagher JA. Recent advances in management of alkaptonuria. J Clin Pathol 2013;66:367-73
   PubMed Web of Science ®Google Scholar
• Festen JJ, Bouman JG, Nienhuis RL. Alkaptonuria, ochronosis and degenerative disorders of the spinal column and joints. Ned Tijdschr Geneeskd 1968;112:1575-85
   PubMedGoogle Scholar
• Parambil JG, Daniels CE, Zehr KJ, et al. Alkaptonuria diagnosed by flexible bronchoscopy. Chest 2005;128:3678-80
   PubMedGoogle Scholar
• Emel E, Karagoz F, Aydin IH, et al. Alkaptonuria with lumbar disc herniation: a report of two cases. Spine 2000;25:2141-4
   PubMedGoogle Scholar
• Akeda K, Kasai Y, Kawakita E, et al. Thoracic myelopathy with Alkaptonuria. Spine 2008;33:E62-5
   PubMedGoogle Scholar
• Rubeli M, Grob D. Lumbar spinal stenosis in systemic diseases and in hereditary syndromes. Orthopade 1993;22:250-6
   PubMedGoogle Scholar
• Farzannia A, Shokouhi G, Hadidchi S. Alkaptonuria and lumbar disc herniation. Report of three cases. J Neuros 2003;98:87-9
   PubMedGoogle Scholar
• Ogata J, Tamura K, Miyanishi K, et al. Anesthesia in a patient with alkaptonuric ochronosis for total hip arthroplasty. Masui 2008;57:439-42
   PubMedGoogle Scholar
• Araki K, Sudo A, Hasegawa M, et al. Devastating ochronotic arthropathy with successful bilateral hip and knee arthroplasties. J Clin Rheumatol 2009;15:138-40
   PubMedGoogle Scholar
• Aquaron R. Alkaptonuria: a very rare metabolic disorder. Indian J Biochem Biophys 2013;50:339-44
   PubMed Web of Science ®Google Scholar
• Kalevski SK, Haritonov DG, Peev NA. Alcaptonuria with lumbar disc prolapse: case study and review of the literature. Spine J 2007;7:495-8
   PubMed Web of Science ®Google Scholar
• Ladjouze-Rezig A, Rodriguez de Cordoba S, Aquaron R. Ochronotic rheumatism in Algeria: clinical, radiological, biological and molecular studies--a case study of 14 patients in 11 families. Joint Bone Spine 2006;73:284-92
   PubMedGoogle Scholar
• Manoj Kumar RV, Rajasekaran S. Spontaneous tendon ruptures in Alkaptonuria. J Bone Joint Surg Br 2003;85:883-6
   PubMedGoogle Scholar
• Chua SY, Chang HC. Bilateral spontaneous rupture of the quadriceps tendon as an initial presentation of alkaptonuria--a case report. Knee 2006;13:408-10
   PubMedGoogle Scholar
• Fisher AA, Davis MW. Alkaptonuric ochronosis with aortic valve and joint replacements and femoral fracture: a case report and literature review. Clin Med Res 2004;2:209-15
   PubMedGoogle Scholar
• Wilke A, Steverding D. Ochronosis as an unusual cause of valvular defect: a case report. J Med Case Reports 2009;3:9302
   PubMedGoogle Scholar
• Pettit SJ, Fisher M, Gallagher JA, et al. Cardiovascular manifestations of Alkaptonuria. J Inherit Metab Dis 2011;34:1177-81
   PubMedGoogle Scholar
• Kragel AH, Lapa JA, Roberts WC. Cardiovascular findings in alkaptonuric ochronosis. Am Heart J 1990;120:1460-3
   PubMedGoogle Scholar
• Brueck M, Bandorski D, Kramer W, et al. Aortic valve stenosis due to alkaptonuria. J Heart Valve Dis 2008;17:127-9
   PubMedGoogle Scholar
• Sanji RR, Reddy KE, Channegowda C. Alkaptonuria: Otolaryngologic clues to diagnosis. Indian J Otol 2011;17:22-5
   Google Scholar
• Srsen S, Vondracek J, Srsnova K, et al. Analysis of the life span of alkaptonuric patients. Cas Lek Cesk 1985;124:1288-91
   PubMedGoogle Scholar
• Montagutelli X, Lalouette A, Coudé M, et al. AKU, a mutation of the mouse homologous to human alkaptonuria, maps to chromosome 16. Genomics 1994;19:9-11
   PubMedGoogle Scholar
• Taylor AM, Preston AJ, Paulk NK, et al. Ochronosis in a murine model of alkaptonuria is synonymous to that in the human condition. Osteoarthritis Cartilage 2012;20:880-6
   PubMed Web of Science ®Google Scholar
• Preston AJ, Keenan CM, Sutherland H, et al. Ochronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinone. Ann Rheum Dis 2014;73:284-9
   PubMed Web of Science ®Google Scholar
• Olah AV, Llyes I, Szoke A, et al. Urinary homogentisic acid in alkaptonuric and healthy children. Clin Chem Lab Med 2003;41:356-9
   PubMedGoogle Scholar
• Usher JL, Ascher DB, Pires DE, et al. Analysis of HGD gene mutations in patients with alkaptonuria from the United Kingdom: Identification of Novel Mutations. JIMD Rep 2015. [Epub ahead of print]
   PubMedGoogle Scholar
• Whybra C, Kampmann C, Krummenauer F, et al. The mainz severity score index: a new instrument for quantifying the anderson-fabry disease phenotype, and the response of patients to enzyme replacement therapy. Clin Genet 2004;65:299-307
   PubMed Web of Science ®Google Scholar
• Sagit M, Uludag M, San I. An unusual dark pigmentation on the tympanic membrane. J Laryngol Otol 2011;125:1059-61
   PubMedGoogle Scholar
• Pau HW. Involvement of the tympanic membrane and ear ossicle system in ochronotic alkaptonuria. Laryngol Rhinol Otol (Stuttg) 1984;63:541-4
   PubMedGoogle Scholar
• Kovacevic M, Simic O, Medved I, et al. Ochronosis of aortic valve and aorta. J Heart Valve Dis 2006;15:730-2
   PubMedGoogle Scholar
• Reddy OJ, Gafoor JA, Suresh B, et al. Alkaptonuria with review of literature. J NTR Univ Health Sci 2014;3:125-9
   Google Scholar
• Mahesh DV, Gunnaiah DC, Chandar V. A rare case of alkaptonuria - achilles tendon rupture. IJHSR 2014;4:323-7
   Google Scholar
• Carter DR, Bouxsein ML, Marcus R. New approaches for interpreting projected bone densitometry data. J Bone Miner Res 1992;7:137-45
   PubMed Web of Science ®Google Scholar
• Guglielmi G, Grimston SK, Fischer KC, et al. Osteoporosis: diagnosis with lateral and posteroanterior dual x-ray absorptiometry compared with quantitative CT. Radiology 1994;192:845-50
   PubMedGoogle Scholar
• Salaffi F, Carotti M, Garofalo G, et al. Radiological scoring methods for ankylosing spondylitis: a comparison between the Bath Ankylosing Spondylitis Radiology Index and the modified Stoke Ankylosing Spondylitis Spine Score. Clin Exp Rheumatol 2007;25:67-74
   PubMedGoogle Scholar
• Ramiro S, van Tubergen A, Stolwijk C, et al. Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke ankylosing spondylitis spine score (mSASSS) or the radiographic ankylosing spondylitis spinal score (RASSS)? Arthritis Res Ther 2013;15:R14
   PubMedGoogle Scholar
• Brandt KD, Fife RS, Braunstein EM, et al. Radiographic grading of the severity of knee osteoarthritis: relation of the Kellgren and Lawrence grade to a grade based on joint space narrowing, and correlation with arthroscopic evidence of articular cartilage degeneration. Arthritis Rheum 1991;34:1381-6
   PubMed Web of Science ®Google Scholar
• McAlindon TE, Watt I, McCrae F, et al. Magnetic resonance imaging in osteoarthritis of the knee: correlation with radiographic and scintigraphic findings. Ann Rheum Dis 1991;50:14-19
   PubMed Web of Science ®Google Scholar
• Terjesen T, Gunderson RB. Radiological evaluation of osteoarthritis of the hip. Acta Orthop 2012;83:185-9
   PubMed Web of Science ®Google Scholar
• Roemer FW, Hunter DJ, Winterstein A, et al. Hip Osteoarthritis MRI Scoring System (HOAMS): reliability and associations with radiographic and clinical findings. Osteoarthritis Cartilage 2011;19:946-62
   PubMedGoogle Scholar
• Kamishima T, Kato M, Atsumi T, et al. Contrast-enhanced whole body joint MR imaging in rheumatoid patients on tumour necrosis factor-alpha agents: a pilot study to evaluate novel scoring system for MR synovitis. Clin Exp Rheumatol 2013;31:154
   PubMed Web of Science ®Google Scholar
• Rennie WJ. Clinical examination or whole-body magnetic resonance imaging: the Holy Grail of spondyloarthritis imaging. Arthritis Res Ther 2012;14:110
   PubMedGoogle Scholar
• Bhargava P, Hanif M, Nash C. Whole-body F-18 sodium fluoride PET-CT in a patient with renal cell carcinoma. Clin Nucl Med 2008;33:894-5
   PubMedGoogle Scholar
• Vinjamuri S, Ramesh CN, Jarvis J, et al. Nuclear medicine techniques in the assessment of alkaptonuria. Nucl Med Commun 2011;32:880-6
   PubMedGoogle Scholar
• Omoumi P, Mercier GA, Lecouvet F, et al. CT Arthrography, MR Arthrography, PET, and Scintigraphy in Osteoarthritis. Radiol Clin North Am 2009;47:595-615
   PubMedGoogle Scholar
• Genovese F, Siebuhr AS, Musa K, et al. Investigating the robustness and diagnostic potential of extracellular matrix remodelling biomarkers in alkaptonuria. JIMD Rep 2015. [Epub ahead of print]
   PubMedGoogle Scholar
• Valenzuela R, Cooperrider PA, Gogate P, et al. Relapsing polychondritis. Immunomicroscopic findings in cartilage of ear biopsy specimens. Hum Pathol 1980;11:19-22
   PubMed Web of Science ®Google Scholar
• Tinti L, Taylor AM, Santucci A, et al. Development of an in vitro model to investigate joint ochronosis in alkaptonuria. Rheumatology (Oxford) 2011;50:271-7
   PubMed Web of Science ®Google Scholar
• Watts RW, Watts RA. Alkaptonuria: a 60-yr follow-up. Rheumatology 2007;46:358-9
   PubMedGoogle Scholar
• Hamamy H. Consanguineous marriages. J Community Genetics 2012;3:185-92
   PubMedGoogle Scholar
• Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22
   PubMed Web of Science ®Google Scholar
• Cannon CP, Giugliano RP, Blazing MA, et al. Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes. Am Heart J 2008;156:826-32
   PubMed Web of Science ®Google Scholar
• Introne WJ, Perry MB, Troendle J, et al. A 3-year randomized therapeutic trial of nitisinone in Alkaptonuria. Mol Genet Metab 2011;103:307-14
   PubMed Web of Science ®Google Scholar
• Keenan CM, Preston A, Sutherland H, et al. Nitisinone arrests but does not reverse ochronosis in alkaptonuric mice. JIMD Rep 2015; Epub ahead of print
   PubMedGoogle Scholar
• Thompson GR. Towards a new era: is coronary artery disease reversible? Cardiology 1990;77(Suppl 4):66-9
   PubMedGoogle Scholar
• Beck M. The Mainz Severity Score Index (MSSI): development and validation of a system for scoring the signs and symptoms of Fabry disease. Acta Pædiatrica Suppl 2006;451:43-6
   Google Scholar
• Lock E, Ranganath LR, Timmis O. The role of nitisinone in tyrosine pathway disorders. Curr Rheumatol Rep 2014;16:457
   PubMed Web of Science ®Google Scholar
• Stewart RM, Briggs MC, Jarvis JC, et al. Reversible keratopathy due to hypertyrosinaemia following intermittent low-dose nitisinone in alkaptonuria: a case report. JIMD Rep 2014; Epub ahead of print
   PubMedGoogle Scholar
• Cerone R, Holme E, Sciaffino MC, et al. Tyrosinaemia type III: diagnosis and 10-year follow-up. Acta Paediat 1997;86:1013-15
   PubMed Web of Science ®Google Scholar
• Willis MS, Basinger AA, Fan Z, et al. Hepatosplenomegaly in an 8-month-old child. Labmedicine 2006;37:665-95
   Google Scholar
• de Laet C, Dionisi-Vici C, Leonard JV, et al. Recommendations for the management of tyrosinaemia type 1. Orphanet J Rare Dis 2013;8:8
   PubMed Web of Science ®Google Scholar
• McKiernan PJ. Nitisinone in the treatment of hereditary tyrosinaemia type I. Drugs 2006;66:743-50
   PubMed Web of Science ®Google Scholar
• Mayorandan S, Meyer U, Gokcay G, et al. Cognitive impairment Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice. Orphanet J Rare Dis 2014;9:107
   PubMed Web of Science ®Google Scholar